The Forge · Self-evaluation
Depression and Anxiety Self-Evaluation
Clinically validated questionnaires used by healthcare providers to screen for depression and anxiety. Choose the tool that best matches what you are experiencing. Results are informational only and do not constitute a medical diagnosis.
PHQ-9
Patient Health Questionnaire-9
Measures depression severity. Recommended if you are experiencing low mood, loss of interest or pleasure, hopelessness, fatigue, or changes in sleep and appetite.
Approx. 2 minutes · 9 questions
GAD-7
Generalized Anxiety Disorder Scale
Measures anxiety severity. Recommended if you are experiencing persistent worry, restlessness, irritability, or difficulty controlling anxious thoughts.
Approx. 2 minutes · 7 questions
MADRS
Montgomery-Asberg Depression Rating Scale
A more detailed clinical depression assessment used by specialists. Recommended for a fuller picture of symptom severity and treatment response.
Approx. 5 minutes · 10 questions
About these tools
These questionnaires are clinically validated screening tools. They are not diagnostic instruments. They measure symptom severity and help identify when a professional evaluation is warranted.
PHQ-9 — Patient Health Questionnaire
Developed by Kroenke, Spitzer, and Williams (2001). Validated across primary care and specialty settings. At a cutoff of 10 or above it shows strong sensitivity and specificity for major depressive disorder.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001. View on PubMed →
GAD-7 — Generalized Anxiety Disorder Scale
Developed by Spitzer et al. (2006) and validated in primary care. Widely used as a brief anxiety screening tool in clinical settings.
Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder. Arch Intern Med. 2006. View on PubMed →
MADRS — Montgomery-Asberg Depression Rating Scale
Developed by Montgomery and Asberg (1979). Commonly used in specialist settings and clinical trials to measure depression severity and change over time.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979. View on PubMed →
The PHQ-9, GAD-7, and MADRS are in the public domain and may be reproduced without permission.
PHQ-9: Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke, and colleagues, with an educational grant from Pfizer Inc.
GAD-7: Developed by Drs. Robert L. Spitzer, Kurt Kroenke, Janet B.W. Williams, and colleagues.
MADRS: Developed by Stuart A. Montgomery and Marie Asberg.
These tools are for informational and educational purposes only. Results do not constitute a medical diagnosis and should not replace evaluation by a licensed clinician. If you are in crisis, call or text 988.